Avoidance – Talk Bio

Novartis Reveals Sustained Efficacy and Safety of Fabhalta in Patients Switching from Anti-C5 Therapies for Paroxysmal Nocturnal Hemoglobinuria (PNH)

5 months ago talkbio0Tagged anti-C5, Avoidance, Blood Transfusion, Effectiveness, Fabhalta, Hemoglobin improvement, Iptacopan, Paroxysmal, Paroxysmal nocturnal hemoglobinuria, PNH, Safety, Switching therapies

Fabhalta (iptacopan), Paroxysmal Nocturnal Hemoglobinuria (PNH), Anti-C5 therapies, Efficacy and safety, Switching therapies, Hemoglobin improvement, Transfusion avoidance

Merck KGaA Evades Legal Action Following DOJ Collaboration on China Export Investigation

11 months ago talkbio0Tagged Avoidance, China, cooperation, DOJ, Evaluation, Export, Imprisonment (finding), Merck KGaA

Merck KGaA, DOJ, China, export scheme, cooperation, investigation, prosecution avoidance

Sen. Wyden Scrutinizes Pfizer’s Tax Rate Amidst Ongoing Investigation

11 months ago talkbio0Tagged Avoidance, Corporate, Drug Industry, Evaluation, financial transparency, Pfizer, Rating (action), Taxation, Wyden

Sen. Wyden, Pfizer, tax rate, investigation, corporate taxation, tax avoidance, pharmaceutical industry, financial transparency